Speciality: Oncology

miCAR: combining microRNA gene silencing with CAR expression 4:17
miCAR: combining microRNA gene silencing with CAR expression
Marco Alessandrini • 20 May 2021
European regulation of advanced therapies 2:19
European regulation of advanced therapies
Aurélie Mahalatchimy • 1 Sep 2020
Cellular therapies: from academia to industry 1:58
Cellular therapies: from academia to industry
Jürgen Kuball • 1 Sep 2020
Meta-analysis: anti-BCMA CAR-T in R/R myeloma 5:03
Meta-analysis: anti-BCMA CAR-T in R/R myeloma
Nico Gagelmann • 1 Sep 2020
Real-world efficacy & safety data: CAR-T in DLBCL 3:05
Real-world efficacy & safety data: CAR-T in DLBCL
Matthew Frigault • 1 Sep 2020
Sharing CAR T-cell data: an EBMT perspective 1:26
Sharing CAR T-cell data: an EBMT perspective
Jürgen Kuball • 1 Sep 2020
Challenges associated with CAR T-cell production 1:45
Challenges associated with CAR T-cell production
Valentín Ortiz-Maldonado • 1 Sep 2020
Gene editing: legal and ethical considerations 5:43
Gene editing: legal and ethical considerations
Aurélie Mahalatchimy • 1 Sep 2020
Gamma delta T-cell therapy 1:35
Gamma delta T-cell therapy
Jürgen Kuball • 1 Sep 2020
Future of anti-BCMA CAR T-cell therapy in myeloma 3:39
Future of anti-BCMA CAR T-cell therapy in myeloma
Noopur Raje • 1 Sep 2020
The potential of gene-edited effector cell therapy 2:40
The potential of gene-edited effector cell therapy
Maksim Mamonkin • 1 Sep 2020
Tocilizumab: CAR T-cell therapy in DLBCL 2:18
Tocilizumab: CAR T-cell therapy in DLBCL
Matthew Frigault • 1 Sep 2020
CAR T-cells: current climate & future perspectives in myeloma 4:18
CAR T-cells: current climate & future perspectives in myeloma
Nico Gagelmann • 1 Sep 2020
Selecting DLBCL patients for CAR T-cell therapies 4:28
Selecting DLBCL patients for CAR T-cell therapies
Anna Sureda • 1 Sep 2020
Sinusoidal obstruction syndrome in patients with R/R B-cell ALL 3:35
Sinusoidal obstruction syndrome in patients with R/R B-cell ALL
Valentín Ortiz-Maldonado • 1 Sep 2020
Role of the EBMT registry on reporting CAR T-cell outcomes 6:56
Role of the EBMT registry on reporting CAR T-cell outcomes
Christian Chabannon • 1 Sep 2020
The content of VJRegenMed is intended for healthcare professionals